Trigeminal autonomic cephalalgia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:157843
Who is this for?
Show terms as
1Active trials28Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Trigeminal autonomic cephalalgia (TAC) refers to a group of primary headache disorders characterized by unilateral head pain occurring in the distribution of the trigeminal nerve, accompanied by prominent ipsilateral cranial autonomic features. This group includes cluster headache, paroxysmal hemicrania, short-lasting unilateral neuralgiform headache attacks (SUNCT/SUNA), and hemicrania continua. The autonomic symptoms that accompany the headache attacks include conjunctival injection (eye redness), lacrimation (tearing), nasal congestion or rhinorrhea, eyelid edema, forehead and facial sweating, miosis (pupil constriction), and ptosis (drooping eyelid), all occurring on the same side as the pain. The underlying pathophysiology involves activation of the trigeminovascular system and the trigeminal-autonomic reflex, with involvement of the hypothalamus playing a central role, particularly in the circadian and circannual periodicity seen in cluster headache. The pain is typically severe to excruciating and can be debilitating, significantly affecting quality of life. TACs primarily affect the nervous system, specifically the trigeminal sensory pathways and parasympathetic autonomic pathways. Treatment varies depending on the specific TAC subtype. Cluster headache is treated acutely with high-flow oxygen and subcutaneous sumatriptan, with verapamil being the most commonly used preventive agent. Paroxysmal hemicrania shows an absolute response to indomethacin, which is considered a diagnostic criterion. SUNCT/SUNA may respond to lamotrigine, and hemicrania continua also responds to indomethacin. Greater occipital nerve blocks and, in refractory cases, neurostimulation techniques (such as occipital nerve stimulation or sphenopalatine ganglion stimulation) may be considered. Early and accurate diagnosis is essential, as each subtype has distinct treatment approaches.

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Mar 2026Response to Combined Trigeminal and Occipital Nerve Stimulation for the Preventive Treatment in Chronic Cluster Headache

Salvia BioElectronics — NA

TrialRECRUITING
Jan 2026Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD - a Pilot Study

Karolinska Institutet — NA

TrialRECRUITING
May 2025Pulsed Radiofrequency Combined With Platelet-Rich Plasma Applied to the Sphenopalatine Ganglion in Treating Episodic Cluster Headache

Beijing Tiantan Hospital

TrialNOT YET RECRUITING
Apr 2025LSD to Improve Cluster Headache Impact Trial

Radboud University Medical Center — PHASE2

TrialRECRUITING
Feb 2025Efficacy of Light Therapy in Treatment of Chronic Cluster Headache

Assistance Publique Hopitaux De Marseille — NA

TrialRECRUITING
Dec 2024nVNS for the Prevention and Treatment of Primary Headache

Nanfang Hospital, Southern Medical University — NA

TrialRECRUITING
Aug 2024A Close Examination of Patient Experiences in Cluster Headache Clinical Research

Power Life Sciences Inc.

TrialNOT YET RECRUITING
May 2023REsponse to Combined SONS and ONS in Chronic Cluster HeadachE

Salvia BioElectronics — NA

TrialACTIVE NOT RECRUITING
Apr 2023Evaluation of the Efficacy of Manual Therapy, Therapeutic Exercise and the Two Modalities Combined in Pain Reduction in Patients With Headache

Campus Bio-Medico University — NA

TrialRECRUITING
Mar 2023Role of Specific microRNAs in Cluster Headache

IRCCS National Neurological Institute "C. Mondino" Foundation

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Trigeminal autonomic cephalalgia.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →
Other1 trial
China HeadAche DIsorders RegiStry
Actively Recruiting
· Sites: Beijing, Beijing Municipality; Beijing, Beijing Municipality +18 more · Age: 1299 yrs

Specialists

Showing 25 of 28View all specialists →
LM
Li Li, MD
Specialist
PI on 2 active trials1 Trigeminal autonomic cephalalgia publication
UD
Urielle Desalbres
Specialist
PI on 21 active trials1 Trigeminal autonomic cephalalgia publication
MP
Mark Burish, MD, PhD
HOUSTON, TX
Specialist
PI on 1 active trial
XM
Xavier MOISSET
Specialist
PI on 3 active trials1 Trigeminal autonomic cephalalgia publication
FM
Fang Luo, M.D.
PHILADELPHIA, PA
Specialist
PI on 5 active trials
NM
Nevcihan ŞAHUTOĞLU BAL, MD
Specialist
PI on 1 active trial
KP
Kees Kramers, Prof.
Specialist
PI on 1 active trial
EP
Erling Tronvik, MD PhD
Specialist
PI on 1 active trial
MP
Michel Ferrari, MD PhD
CUPERTINO, CA
Specialist
PI on 1 active trial
SM
Scott B. Phillips, M.D.
Specialist
PI on 1 active trial
DP
Don Kellerman, PharmD
Specialist
PI on 1 active trial
PM
Paul Frank, MD
Specialist
PI on 1 active trial
KD
Kaiming Liu, Doctor
Specialist
PI on 1 active trial
SM
Silvia Sterzi, MD
Specialist
PI on 1 active trial
MP
Messoud Ashina, MD, PhD
Specialist
PI on 1 active trial
KP
Kaare Meier, MD PhD
Specialist
PI on 2 active trials
NM
Nunu Lund, MD
Specialist
PI on 1 active trial
GP
Geirmund Unsgård, MD PhD prof
Specialist
PI on 1 active trial
LS
Lia Spitzer
FOXBORO, MA
Specialist
PI on 1 active trial
AM
Amir Radfar, M.D,MPH
Specialist
PI on 1 active trial
AM
Alexander D Nesbitt, BM BCh MRCP
Specialist
PI on 1 active trial
PP
Piero Barbanti, MD, PhD
Specialist
PI on 1 active trial
AP
Arne May, MD, PhD
Specialist
PI on 1 active trial
FM
Faro T Owiesy, M.D.
CORONA, CA
Specialist
PI on 1 active trial
RP
Rigmor Jensen, Professor
Specialist
PI on 1 active trial2 Trigeminal autonomic cephalalgia publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Trigeminal autonomic cephalalgia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Trigeminal autonomic cephalalgiaForum →

No community posts yet. Be the first to share your experience with Trigeminal autonomic cephalalgia.

Start the conversation →

Latest news about Trigeminal autonomic cephalalgia

Disease timeline:

New recruiting trial: LSD to Improve Cluster Headache Impact Trial

A new clinical trial is recruiting patients for Trigeminal autonomic cephalalgia

New recruiting trial: nVNS for the Prevention and Treatment of Primary Headache

A new clinical trial is recruiting patients for Trigeminal autonomic cephalalgia

New recruiting trial: Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD - a Pilot Study

A new clinical trial is recruiting patients for Trigeminal autonomic cephalalgia

New recruiting trial: Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache

A new clinical trial is recruiting patients for Trigeminal autonomic cephalalgia

New recruiting trial: Repeated GON Injections in CCH

A new clinical trial is recruiting patients for Trigeminal autonomic cephalalgia

New recruiting trial: Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster Headache

A new clinical trial is recruiting patients for Trigeminal autonomic cephalalgia

New recruiting trial: Ketamine + Magnesium for Chronic Cluster Headache (KETALGIA)

A new clinical trial is recruiting patients for Trigeminal autonomic cephalalgia

New recruiting trial: Efficacy of Light Therapy in Treatment of Chronic Cluster Headache

A new clinical trial is recruiting patients for Trigeminal autonomic cephalalgia

New recruiting trial: Response to Combined Trigeminal and Occipital Nerve Stimulation for the Preventive Treatment in Chronic Cluster Headache

A new clinical trial is recruiting patients for Trigeminal autonomic cephalalgia

New recruiting trial: China Headache and Vertigo Registry Study

A new clinical trial is recruiting patients for Trigeminal autonomic cephalalgia

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Trigeminal autonomic cephalalgia

What is Trigeminal autonomic cephalalgia?

Trigeminal autonomic cephalalgia (TAC) refers to a group of primary headache disorders characterized by unilateral head pain occurring in the distribution of the trigeminal nerve, accompanied by prominent ipsilateral cranial autonomic features. This group includes cluster headache, paroxysmal hemicrania, short-lasting unilateral neuralgiform headache attacks (SUNCT/SUNA), and hemicrania continua. The autonomic symptoms that accompany the headache attacks include conjunctival injection (eye redness), lacrimation (tearing), nasal congestion or rhinorrhea, eyelid edema, forehead and facial sweati

How is Trigeminal autonomic cephalalgia inherited?

Trigeminal autonomic cephalalgia follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Trigeminal autonomic cephalalgia typically begin?

Typical onset of Trigeminal autonomic cephalalgia is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Trigeminal autonomic cephalalgia?

Yes — 1 recruiting clinical trial is currently listed for Trigeminal autonomic cephalalgia on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Trigeminal autonomic cephalalgia?

25 specialists and care centers treating Trigeminal autonomic cephalalgia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.